Nutex Health, Inc. financial data

Symbol
NUTX on Nasdaq
Location
Houston, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 210% % 37%
Quick Ratio 1.6% % -65%
Debt-to-equity 233% % -57%
Return On Equity 40% %
Return On Assets 15% %
Operating Margin 37% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7,071,916 shares 30%
Common Stock, Shares, Outstanding 6,905,262 shares 32%
Entity Public Float $18,200,000 USD -87%
Common Stock, Value, Issued $7,000 USD 34%
Weighted Average Number of Shares Outstanding, Basic 6,701,240 shares 31%
Weighted Average Number of Shares Outstanding, Diluted 7,177,528 shares 41%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $981,195,716 USD 236%
General and Administrative Expense $46,577,842 USD 24%
Costs and Expenses $441,427,356 USD 97%
Operating Income (Loss) $358,916,398 USD 1249%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $327,464,934 USD
Income Tax Expense (Benefit) $63,746,746 USD 2121%
Net Income (Loss) Attributable to Parent $120,650,604 USD
Earnings Per Share, Basic 20 USD/shares
Earnings Per Share, Diluted 19 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $166,048 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current $62,745,336 USD 18%
Inventory, Net $3,158,000 USD 40%
Other Assets, Current $313,847,000 USD
Assets, Current $473,025,000 USD 315%
Deferred Income Tax Assets, Net $0 USD
Operating Lease, Right-of-Use Asset $27,354,000 USD 139%
Intangible Assets, Net (Excluding Goodwill) $21,555,000 USD 36%
Goodwill $13,919,000 USD 0%
Other Assets, Noncurrent $499,000 USD
Assets $964,518,000 USD 120%
Accounts Payable, Current $19,836,000 USD 15%
Liabilities, Current $185,456,000 USD 175%
Deferred Income Tax Liabilities, Net $14,955,000 USD 339%
Operating Lease, Liability, Noncurrent $30,423,000 USD 113%
Other Liabilities, Noncurrent $310,470,000 USD
Liabilities $526,485,000 USD 47%
Retained Earnings (Accumulated Deficit) $298,021,000 USD 29%
Stockholders' Equity Attributable to Parent $317,166,000 USD 425%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $438,033,000 USD 449%
Liabilities and Equity $964,518,000 USD 120%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $50,965,000 USD 1570%
Net Cash Provided by (Used in) Financing Activities $6,812,000 USD -220%
Net Cash Provided by (Used in) Investing Activities $64,000 USD 91%
Common Stock, Shares Authorized 950,000,000 shares 0%
Common Stock, Shares, Issued 6,905,262 shares 32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $84,729,000 USD
Interest Paid, Excluding Capitalized Interest, Operating Activities $608,000 USD 11%
Deferred Tax Assets, Valuation Allowance $944,330 USD -87%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 49%
Deferred Tax Assets, Gross $74,535,389 USD 14%
Payments to Acquire Property, Plant, and Equipment $64,000 USD -91%
Property, Plant and Equipment, Gross $112,851,000 USD 11%
Operating Lease, Liability, Current $2,111,000 USD 2.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 100%
Deferred Income Tax Expense (Benefit) $2,500,000 USD -2532%
Deferred Tax Assets, Operating Loss Carryforwards $0 USD -100%
Additional Paid in Capital $615,180,000 USD 28%
Amortization of Intangible Assets $1,400,000 USD -6.7%
Depreciation, Depletion and Amortization $20,623,972 USD 0.62%
Share-based Payment Arrangement, Expense $15,942,000 USD
Interest Expense $17,622,142 USD 28%